An effectiveness and safety study of herbal extract product comparing to standard treatment in male and female androgenetic alopecia
Phase 4
Completed
- Conditions
- An effectiveness and safety study of herbal extract product comparing to standard treatment in male and female androgenetic alopeciaAndrogenetic alopecia
- Registration Number
- TCTR20220927001
- Lead Sponsor
- Srinakharinwirot University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Male (Norwood-Hamilton classification of IIa - V)
Females (Ludwig classification of I-4, II-1, II-2)
No history of allergic reaction following study topical drug used
Older than 18 years
Exclusion Criteria
-Used the following medications within 6 months prior to screening : minoxidil, finasteride, medication with anti-androgenic properties, estrogen, progesterone, tamoxifen, anabolic steroid and oral contraceptive drugs.
-Hair transplant within 1 year
-Pregnancy
-Breast feeding
-Abnormal thyroid function test
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of herbal extract products in treating androgenetic alopecia compared to standard treatments like minoxidil or finasteride?
What clinical evidence supports the comparative effectiveness of herbal extracts versus conventional androgenetic alopecia therapies in phase IV trials?
Which biomarkers are associated with response prediction to herbal extract treatments in androgenetic alopecia patients?
What are the potential adverse events and safety profiles of herbal extract products in phase IV androgenetic alopecia studies?
How do herbal extract products compare to competitor drugs in targeting androgen receptors for androgenetic alopecia treatment?